The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
IgA Nephropathy
Open accessAbstract
IgA nephropathy (IgAN) is a leading cause of CKD and renal failure. Recent international collaborative efforts have led to important discoveries that have improved our understanding of some of the key steps involved in the immunopathogenesis of IgAN. Furthermore, establishment of multicenter networks has contributed to rigorous design and execution of clinical trials that have provided important insights regarding immunotherapy in IgAN. In this article, we review emerging developments in clinical and translational IgAN research and describe how these novel findings will influence future strategies to improve the outcome of patients with IgAN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationMycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L.-S., Mysler, E., Sa[Combining Acute Accent]nchez-Guerrero, J., Solomons, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101028 · Cited by 1,118
An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway
Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulga-Morskaya, S., Dobles, M., Frew, E., & Scott, M. L. (2001) · Science · doi:10.1126/science.1061964 · Cited by 1,069
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts, I. S. D., Cook, H. T., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., Berthoux, F., Bonsib, S., Bruijn, J. A., et al. (2009) · Kidney International · doi:10.1038/ki.2009.168 · Cited by 1,038
Self-citation(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
KDIGO Clinical Practice Guideline for Glomerulonephritis
Eckardt, K., & Kasiske, B. L. (2012) · Cited by 893
The incidence of primary glomerulonephritis worldwide: a systematic review of the literature
McGrogan, A., Franssen, C. F. M., & de Vries, C. S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq665 · Cited by 741
Intensive supportive care plus immunosuppression in IgA nephropathy
Rauen, T., Eitner, F., Fitzner, C., Sommerer, C., Zeier, M., Otte, B., Panzer, U., Peters, H., Benck, U., Mertens, P. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415463 · Cited by 726
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Reich, H. N., Troyanov, S. A. A., Scholey, J. W., & Cattran, D. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050526 · Cited by 639
Self-citationKiryluk, K., Li, Y., Scolari, F., Sanna-Cherchi, S., Choi, M., Verbitsky, M., Fasel, D., Lata, S., Prakash, S., Shapiro, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.3118 · Cited by 628
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Gharavi, A. G., Kiryluk, K., Choi, M., Li, Y., Hou, P., Xie, J., Sanna-Cherchi, S., Men, C. J., Julian, B. A., Wyatt, R. J., et al. (2011) · Nature Genetics · doi:10.1038/ng.787 · Cited by 624
Corticosteroids in IgA nephropathy: a randomised controlled trial
Pozzi, C., Bolasco, P., Fogazzi, G., Andrulli, S., Altieri, P., Ponticelli, C., & Locatelli, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03563-6 · Cited by 532
Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome
D’Amico, G. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.01.001 · Cited by 500
Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors
D’Amico, G. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8966 · Cited by 499
Coppo, R., on behalf of the VALIGA study of the ERA-EDTA Immunonephrology Working Group, Troyanov, S., Bellur, S., Cattran, D., Cook, H. T., Feehally, J., Roberts, I. S. D., Morando, L., Camilla, R., et al. (2014) · Kidney International · doi:10.1038/ki.2014.63 · Cited by 498
Corticosteroid Effectiveness in IgA Nephropathy: Long-Term Results of a Randomized, Controlled Trial
Pozzi, C., Andrulli, S., Del Vecchio, L., Melis, P., Fogazzi, G. B., Altieri, P., Ponticelli, C., & Locatelli, F. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000103869.08096.4f · Cited by 484
Roos, A., Rastaldi, M. P., Calvaresi, N., Oortwijn, B. D., Schlagwein, N., van Gijlswijk-Janssen, D. J., Stahl, G. L., Matsushita, M., Fujita, T., van Kooten, C., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090923 · Cited by 450
Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway
Roos, A., Bouwman, L. H., van Gijlswijk-Janssen, D. J., Faber-Krol, M. C., Stahl, G. L., & Daha, M. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2861 · Cited by 431
Kiryluk, K., Li, Y., Sanna-Cherchi, S., Rohanizadegan, M., Suzuki, H., Eitner, F., Snyder, H. J., Choi, M., Hou, P., Scolari, F., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002765 · Cited by 383
Current Understanding of the Role of Complement in IgA Nephropathy
Maillard, N., Wyatt, R. J., Julian, B. A., Kiryluk, K., Gharavi, A., Fremeaux-Bacchi, V., & Novak, J. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101000 · Cited by 338
Controlled Prospective Trial of Prednisolone and Cytotoxics in Progressive IgA Nephropathy
Ballardie, F. W., & Roberts, I. S. D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131142 · Cited by 317
Yu, X.-Q., Li, M., Zhang, H., Low, H.-Q., Wei, X., Wang, J.-Q., Sun, L.-D., Sim, K.-S., Li, Y., Foo, J.-N., et al. (2012) · Nature Genetics · doi:10.1038/ng.1047 · Cited by 312
Manno, C., Torres, D. D., Rossini, M., Pesce, F., & Schena, F. P. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp356 · Cited by 311
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
Magistroni, R., D’Agati, V. D., Appel, G. B., & Kiryluk, K. (2015) · Kidney International · doi:10.1038/ki.2015.252 · Cited by 302
Lafayette, R. A., Canetta, P. A., Rovin, B. H., Appel, G. B., Novak, J., Nath, K. A., Sethi, S., Tumlin, J. A., Mehta, K., Hogan, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060640 · Cited by 300
Incidence of latent mesangial IgA deposition in renal allograft donors in Japan
Suzuki, K., Honda, K., Tanabe, K., Toma, H., Nihei, H., & Yamaguchi, Y. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.6s.2.x · Cited by 296
The MEST score provides earlier risk prediction in lgA nephropathy
Barbour, S. J., Espino-Hernandez, G., Reich, H. N., Coppo, R., Roberts, I. S. D., Feehally, J., Herzenberg, A. M., Cattran, D. C., Bavbek, N., Cook, T., et al. (2016) · Kidney International · doi:10.1038/ki.2015.322 · Cited by 292
Self-citationMice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy
McCarthy, D. D., Kujawa, J., Wilson, C., Papandile, A., Poreci, U., Porfilio, E. A., Ward, L., Lawson, M. A. E., Macpherson, A. J., McCoy, K. D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45563 · Cited by 286
Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
Gharavi, A. G., Moldoveanu, Z., Wyatt, R. J., Barker, C. V., Woodford, S. Y., Lifton, R. P., Mestecky, J., Novak, J., & Julian, B. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091052 · Cited by 284
Kiryluk, K., Moldoveanu, Z., Sanders, J. T., Eison, T. M., Suzuki, H., Julian, B. A., Novak, J., Gharavi, A. G., & Wyatt, R. J. (2011) · Kidney International · doi:10.1038/ki.2011.16 · Cited by 266
Ibels, L. S., & Györy, A. Z. (1994) · Medicine · doi:10.1097/00005792-199403000-00002 · Cited by 244
Frisch, G., Lin, J., Rosenstock, J., Markowitz, G., D'Agati, V., Radhakrishnan, J., Preddie, D., Crew, J., Valeri, A., & Appel, G. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh974 · Cited by 244
Lv, J., Zhang, H., Chen, Y., Li, G., Jiang, L., Singh, A. K., & Wang, H. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.07.029 · Cited by 238
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study
Tesar, V., Troyanov, S., Bellur, S., Verhave, J. C., Cook, H. T., Feehally, J., Roberts, I. S. D., Cattran, D., & Coppo, R. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070697 · Cited by 217
Szeto, C.-C., Lai, F. M.-M., To, K.-F., Yuk-Hwa Wong, T., Chow, K.-M., Cheung-Lung Choi, P., Lui, S.-F., & Kam-Tao Li, P. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00659-3 · Cited by 212
Validation of the Oxford classification of IgA nephropathy
Herzenberg, A. M., Fogo, A. B., Reich, H. N., Troyanov, S., Bavbek, N., Massat, A. E., Hunley, T. E., Hladunewich, M. A., Julian, B. A., Fervenza, F. C., et al. (2011) · Kidney International · doi:10.1038/ki.2011.126 · Cited by 211
Self-citationMycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy
Tang, S., Leung, J. C. K., Chan, L. Y. Y., Lui, Y. H., Tang, C. S. O., Kan, C. H., Ho, Y. W., & Lai, K. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00460.x · Cited by 198
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Tang, S. C. W., Tang, A. W. C., Wong, S. S. H., Leung, J. C. K., Ho, Y. W., & Lai, K. N. (2010) · Kidney International · doi:10.1038/ki.2009.499 · Cited by 192
Corticosteroid therapy in IgA nephropathy
Lv, J., Xu, D., Perkovic, V., Ma, X., Johnson, D. W., Woodward, M., Levin, A., Zhang, H., & Wang, H. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111112 · Cited by 190
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
Knoppova, B., Reily, C., Maillard, N., Rizk, D. V., Moldoveanu, Z., Mestecky, J., Raska, M., Renfrow, M. B., Julian, B. A., & Novak, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00117 · Cited by 187
Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria
Gutiérrez, E., Zamora, I., Ballarín, J. A., Arce, Y., Jiménez, S., Quereda, C., Olea, T., Martínez-Ara, J., Segarra, A., Bernis, C., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010063 · Cited by 185
Evaluation of the Oxford Classification of IgA Nephropathy: A Systematic Review and Meta-analysis
Lv, J., Shi, S., Xu, D., Zhang, H., Troyanov, S., Cattran, D. C., & Wang, H. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.04.021 · Cited by 177
Risk Stratification of Patients With IgA Nephropathy
Barbour, S. J., & Reich, H. N. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.326 · Cited by 174
Self-citationBarbour, S. J., Cattran, D. C., Kim, S. J., Levin, A., Wald, R., Hladunewich, M. A., & Reich, H. N. (2013) · Kidney International · doi:10.1038/ki.2013.210 · Cited by 164
Self-citationZhu, L., Zhai, Y.-L., Wang, F.-M., Hou, P., Lv, J.-C., Xu, D.-M., Shi, S.-F., Liu, L.-J., Yu, F., Zhao, M.-H., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010096 · Cited by 164
Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
Pozzi, C., Andrulli, S., Pani, A., Scaini, P., Vecchio, L. D., Fogazzi, G., Vogt, B., Cristofaro, V. D., Allegri, L., Cirami, L. C., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010117 · Cited by 149
Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
Zhai, Y., Zhu, L., Shi, S., Liu, L., Lv, J., & Zhang, H. (2016) · Medicine · doi:10.1097/md.0000000000003099 · Cited by 140
Smerud, H. K., Barany, P. F., Lindstrom, K., Fernström, A., Sandell, A., Påhlsson, P., & Fellström, B. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr052 · Cited by 139
Hogg, R. J., Bay, R. C., Jennette, J. C., Sibley, R. K., Kumar, S., Fervenza, F. C., Appel, G. B., Cattran, D., Fischer, D., Hurley, R. M., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.06.013 · Cited by 125
Prediction of Outcomes in Crescentic IgA Nephropathy in a Multicenter Cohort Study
Lv, J., Yang, Y., Zhang, H., Chen, W., Pan, X., Guo, Z., Wang, C., Li, S., Zhang, J., Zhang, J., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101017 · Cited by 118
Cigarette Smoking and Progression of IgA Nephropathy
Yamamoto, R., Nagasawa, Y., Shoji, T., Iwatani, H., Hamano, T., Kawada, N., Inoue, K., Uehata, T., Kaneko, T., Okada, N., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.02.351 · Cited by 103
Varis, J., Rantala, I. S., Pasternack, A. I., et al. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.7.607 · Cited by 82
Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy
Buemi, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.105330 · Cited by 78
IgA Nephropathy with Minimal Change Disease
Herlitz, L., Bomback, A. S., Stokes, M. B., Radhakrishnan, J., D’Agati, V. D., & Markowitz, G. S. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11951113 · Cited by 75
Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy
Berthoux, F. C., Mariat, C., & Maillard, N. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft286 · Cited by 69
Incidence of pediatric IgA nephropathy
Utsunomiya, Y., Koda, T., Kado, T., Okada, S.-I., Hayashi, A., Kanzaki, S., Kasagi, T., Hayashibara, H., & Okasora, T. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1127-z · Cited by 67
Aortic Embolism in Claude’s Syndrome
Kremer, C., & Baumgartner, R. W. (2002) · Cerebrovascular Diseases · doi:10.1159/000047764 · Cited by 61
Lamm, M. E., Emancipator, S. N., Robinson, J., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070131 · Cited by 50
Pozzi, C., Andrulli, S., Pani, A., Scaini, P., Roccatello, D., Fogazzi, G., Pecchini, P., Rustichelli, R., Finocchiaro, P., Vecchio, L. D., et al. (2012) · Journal of Nephrology · doi:10.5301/jn.5000110 · Cited by 49
Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy
Huang, Z. Q., Raška, M., Stewart, T. J., Reily, C., King, R. G., Crossman, D. K., Crowley, M. R., Hargett, A. A., Zhang, Z., Suzuki, H., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101044 · Cited by 39
Kittiskulnam, P., Kanjanabuch, T., Tangmanjitjaroen, K., Chancharoenthana, W., Praditpornsilpa, K., & Eiam‐Ong, S. (2014) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2014.01.016 · Cited by 28
Emerging therapies in immunoglobulin A nephropathy
Yeo, S. C., Liew, A., & Barratt, J. (2015) · Nephrology · doi:10.1111/nep.12527 · Cited by 24
Tian, L., Shao, X., Xie, Y., Wang, X., Wang, Q., Che, X., Ni, Z., & Mou, S. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1038238 · Cited by 11
Cited by
Murdaca, G., Tonacci, A., Negrini, S., Greco, M., Borro, M., Puppo, F., & Gangemi, S. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102350 · Cited by 306
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Stenvinkel, P., Chertow, G. M., Devarajan, P., Levin, A., Andreoli, S. P., Bangalore, S., & Warady, B. A. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.04.023 · Cited by 297
Metadata
- Authors
- Rodrigues, J. C., Haas, M., & Reich, H. N.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-02-03
- Volume
- 12
- Issue
- 4
- Pages
- 677-686
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2586394131
- Cited by
- 555
- References
- 63
- FWCI
- 19.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.